B2B pharmacy marketplace Saveo raised $3.47 million in seed led by LC Nueva Alternative Investment Fund (AIF), Jetty Ventures and Gunosy Capital Partners.
Saveo operates a marketplace that connects pharmaceutical companies and retailers to buy surgical, homoeopathic, and allopathic medicines. It also has another vertical that allows traditional pharmacy stores to digitise their operations. The funding will be used by the pharmacy startup to accelerate growth and expand its footprint across the country. Saveo will also use the funds to fund capital expenditures and meet its current working capital needs.
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
B2B pharmacy marketplace Saveo raised $3.47 million in seed led by LC Nueva Alternative Investment Fund (AIF), Jetty Ventures and Gunosy Capital Partners.
Saveo operates a marketplace that connects pharmaceutical companies and retailers to buy surgical, homoeopathic, and allopathic medicines. It also has another vertical that allows traditional pharmacy stores to digitise their operations. The funding will be used by the pharmacy startup to accelerate growth and expand its footprint across the country. Saveo will also use the funds to fund capital expenditures and meet its current working capital needs.
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
